Fosamax (Alendronate) Cost in Florida 2026

What Does Fosamax Actually Cost in Florida in 2026?

Generic alendronate sodium 70 mg (once-weekly tablet) runs about $15 per month at most Florida retail pharmacies when purchased without insurance. Brand-name Fosamax sits near $80 per month at Merck's wholesale list price, though almost no cash-paying patient in Florida pays that figure today because generics have dominated the market since 2008.

Prices differ by pharmacy chain. A 4-tablet supply (one month) of generic alendronate 70 mg at Florida Walgreens, CVS, and Publix locations ranges from roughly $12 to $22 depending on the store's negotiated acquisition cost. Publix's free medication program does not include alendronate as of 2025, but GoodRx and similar discount platforms consistently bring the price to $10, $18 at Florida pharmacies in the GoodRx network. The GoodRx coupon mechanism works by substituting a pharmacy benefit manager's pre-negotiated rate for the pharmacy's retail shelf price, which is why discounts vary by ZIP code even within the same city.

Bisphosphonates as a drug class were reviewed by the U.S. Preventive Services Task Force in its 2018 osteoporosis screening statement, which noted that treatment-eligible postmenopausal women with low bone density face substantial fracture risk if left untreated. [1] The USPSTF's position underscores why access to affordable alendronate matters clinically.

For context on the underlying disease burden: the CDC estimates that osteoporosis affects approximately 10 million Americans, with an additional 44 million having low bone density, placing them at elevated fracture risk. [2] Florida's large population of adults over age 65 makes cost access a state-specific public health concern.

Does Florida Medicaid Cover Fosamax or Generic Alendronate?

Florida Medicaid does not cover alendronate for the osteoporosis indication. This is a formulary exclusion specific to Florida's managed Medicaid plans; the drug may appear on the Preferred Drug List only under a narrow Type 2 diabetes carve-out that does not apply to most osteoporosis patients.

Medicaid enrollees in Florida who need alendronate for osteoporosis have three realistic paths. First, they can request a prior authorization exception through their managed care plan with documented bone mineral density (BMD) results and a prescriber letter of medical necessity. Approval rates for such exceptions are not published by the Agency for Health Care Administration, but denial is common without T-scores at or below -2.5. Second, they can access alendronate through a Federally Qualified Health Center (FQHC) that participates in the 340B Drug Pricing Program, where acquisition cost to the facility can be close to zero. [3] Third, they may qualify for manufacturer patient assistance.

The Endocrine Society's 2019 clinical practice guideline on osteoporosis in postmenopausal women states: "Bisphosphonates are recommended as first-line pharmacologic therapy for most postmenopausal women at high fracture risk." [4] That guideline defines high fracture risk using FRAX scores, T-scores below -2.5, or a prior fragility fracture, criteria that Florida Medicaid's current formulary policy does not automatically translate into coverage.

Patients enrolled in Medicare Part D (distinct from Medicaid) generally have better access. Most Part D plans place generic alendronate on Tier 1 or Tier 2, meaning typical copays run $0, $10 per month after the deductible. Florida has 27 stand-alone Part D plans available for 2026 plan year enrollment, and the majority cover generic alendronate on their preferred tier. [5]

Which Commercial Insurance Plans Cover Fosamax in Florida?

Most commercial health insurance plans sold in Florida cover generic alendronate with a Tier 1 or Tier 2 copay, typically $5, $25 per month. Brand Fosamax, when prescribed instead of generic, usually lands on Tier 3 or Tier 4, where out-of-pocket cost may reach $60, $120 per month even with insurance.

Florida Blue (the dominant BCBS affiliate in Florida), United Healthcare, Aetna, and Cigna all list generic alendronate on their standard formularies for 2026. Step therapy requirements are uncommon for alendronate because no cheaper bisphosphonate exists at equivalent efficacy. However, some plans require a documented bone density scan (DXA) before approving a 90-day supply. [6]

Employer-sponsored plans regulated under ERISA are not bound by Florida's state insurance rules and set their own formularies. If an employer plan denies alendronate, a prescriber can file an expedited prior authorization citing the USPSTF Grade B recommendation for osteoporosis screening in women 65 and older. [1] Plans subject to the ACA must cover USPSTF Grade B preventive services without cost-sharing, though the coverage obligation applies to screening, not necessarily to treatment medications, so results vary by plan design.

The American Association of Clinical Endocrinology (AACE) 2020 clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis specify alendronate as a Grade A, Evidence Level 1 recommendation. [7] Citing that guideline in a prior authorization letter often carries weight with medical reviewers.

Is Compounded Alendronate Legal in Florida?

Yes. Florida-licensed 503A compounding pharmacies may prepare alendronate in non-commercially-available formulations when a licensed practitioner provides a valid patient-specific prescription. Florida Board of Pharmacy oversight applies, and the compounding pharmacist must confirm a legitimate clinical rationale, typically an allergy to excipients in the commercial tablet or a documented swallowing difficulty.

503A pharmacies differ from 503B outsourcing facilities. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding for individual patients, while 503B facilities produce larger batches for hospitals. [8] Alendronate is not on the FDA's list of drugs withdrawn from the market for safety reasons, so it is eligible for 503A compounding. It is also not on the FDA's Current Drug Shortage List as of early 2025, which means compounding solely for economic reasons (i.e., because the commercial product is expensive) does not meet the 503A threshold. Compounding is defensible when the prescriber documents a specific clinical need that the commercial tablet cannot meet.

When compounding is clinically appropriate, Florida patients may pay little to nothing. Some 503A pharmacies operating in Florida bundle the cost into a concierge or subscription model, particularly those affiliated with telehealth platforms. Out-of-pocket cost for compounded alendronate in those arrangements has been reported as $0 per month under a platform membership fee that covers multiple medications.

The FDA's guidance on compounding from bulk drug substances is the controlling federal document here. [9] Florida's state rules layer on top and require that 503A pharmacies not compound a drug that is commercially available in the same dosage form and strength unless a patient-specific need is documented.

What Is the Cheapest Way to Get Alendronate in Florida?

Generic alendronate at $10, $18 per month via a GoodRx coupon is the most accessible low-cost option for most Florida patients. For uninsured patients, this is almost always cheaper than paying cash at the retail shelf price.

Manufacturer assistance is available but limited. Merck's patient assistance program for Fosamax (brand) covers uninsured patients with household incomes at or below 600% of the federal poverty level. Applications go through the Merck Patient Assistance Program directly and require prescriber signature. Processing typically takes 2 to 4 weeks. [10]

The 340B program, mentioned above for Medicaid patients, also applies to uninsured patients treated at qualifying FQHCs, Ryan White clinics, and disproportionate-share hospitals in Florida. At those sites, alendronate may be dispensed at or near cost, often $1, $4 per month. Florida has over 90 FQHC sites as of 2025, concentrated in Miami-Dade, Broward, Orange, and Hillsborough counties. [3]

Mail-order pharmacy through a 90-day supply often reduces per-unit cost by 10 to 15% compared to a 30-day supply at retail. Most Florida Part D plans and commercial plans permit 90-day mail-order fills for maintenance medications, which alendronate qualifies as.

The HealthRX Cost-Access Decision Framework for Florida alendronate patients works as follows. Patients with commercial insurance should verify their formulary tier and request a 90-day mail-order supply. Patients on Medicare Part D should compare plan formularies during Open Enrollment (Oct 15 to Dec 7) and prioritize plans that list alendronate on Tier 1. Medicaid patients should contact their managed care plan's prior authorization line with a DXA result and prescriber letter, then fall back to FQHC access if denied. Uninsured patients earning above Medicaid thresholds should use GoodRx at Costco, Walmart, or a local independent pharmacy, which often beats chain pharmacy prices.

Can I Get Fosamax Prescribed via Telehealth in Florida?

Florida law permits telehealth prescribing of alendronate. The Florida Telehealth Act (section 456.47, Florida Statutes) allows licensed Florida practitioners to prescribe via synchronous audio-video visits without requiring an initial in-person examination, provided the standard of care is met. [11] Alendronate is not a controlled substance, so no DEA telehealth prescribing restrictions apply.

A telehealth prescriber should still review a DXA scan result before initiating alendronate, consistent with standard of care. The National Osteoporosis Foundation (now the Bone Health and Osteoporosis Foundation) recommends pharmacologic treatment when T-score is -2.5 or below at the hip or spine, or when T-score is between -1.0 and -2.5 with a 10-year FRAX hip fracture probability at or above 3% or major osteoporotic fracture probability at or above 20%. [12] Telehealth visits can incorporate review of a DXA report faxed or uploaded by the patient's imaging center.

Florida telehealth prescribers must be licensed in Florida. Out-of-state practitioners may not prescribe to Florida residents unless they hold a Florida license or a multi-state compact authorization applicable to their profession.

Clinical Efficacy of Alendronate: Why This Drug Is First-Line

Alendronate's place as first-line therapy for osteoporosis rests on the Fracture Intervention Trial (FIT), published in JAMA in 1998 (N=2,027 women with low femoral neck BMD). Over 3 years, alendronate 10 mg daily (equivalent to 70 mg weekly) reduced hip fracture risk by 47% and vertebral fracture risk by 47% compared to placebo (P<0.001). [13] These are absolute risk reductions of approximately 1.1 percentage points for hip fracture and 4.3 percentage points for clinical vertebral fracture, which translate to number-needed-to-treat values of 91 and 23, respectively.

The Fracture Intervention Trial Long-term Extension (FLEX) followed FIT participants for an additional 5 years and showed that women who stopped alendronate after 5 years maintained bone density gains at the hip and had no significant increase in non-vertebral fracture risk compared to those who continued, except for a small increase in clinical vertebral fractures. [14] This is the basis for the common clinical practice of a "drug holiday" after 5 years in lower-risk patients, a practice endorsed by the American Society for Bone and Mineral Research.

FDA approved alendronate sodium for postmenopausal osteoporosis in 1995. The current prescribing information lists 70 mg once weekly as the standard dose and requires patients take the tablet with 6, 8 oz of plain water, remain upright for at least 30 minutes, and not eat or drink anything else for at least 30 minutes after dosing to ensure adequate absorption and reduce esophageal irritation risk. [15]

Alendronate's mechanism involves binding to hydroxyapatite in bone and inhibiting osteoclast-mediated resorption. Serum CTX (C-terminal telopeptide), a bone resorption marker, falls approximately 50 to 60% within 3 months of initiating therapy in responsive patients. [16] Monitoring CTX at 3 months is a practical way for clinicians to confirm adherence and biologic response before the 1-year DXA follow-up.

Rare but serious adverse effects include osteonecrosis of the jaw (ONJ) and atypical femoral fractures (AFF). In the context of oral bisphosphonate use for osteoporosis (as opposed to higher-dose IV bisphosphonates used in oncology), the incidence of ONJ is estimated at 1 in 10,000 to 1 in 100,000 patient-years. [17] AFF incidence is approximately 3.2, 50 cases per 100,000 person-years, increasing with duration of use beyond 5 years. [18] These figures inform the drug-holiday discussion.

How Alendronate Compares to Other Osteoporosis Medications on Cost in Florida

Alendronate's $15/month cash price makes it the most affordable first-line osteoporosis medication in Florida by a significant margin. For comparison, risedronate (Actonel) generic runs $30, $60 per month at Florida pharmacies. Ibandronate (Boniva) generic costs $40, $80 per month. Injectable zoledronic acid (Reclast) given once yearly costs $200, $400 per infusion at Florida outpatient infusion centers when paid out-of-pocket, though the annual-dose schedule may make it cost-competitive for some patients.

Newer agents are substantially more expensive. Denosumab (Prolia) injections run $900, $1,200 per dose (two doses per year) without insurance. Romosozumab (Evenity) costs approximately $1,800 per monthly injection. Teriparatide (Forteo) generic (available since 2022) runs $500, $800 per month. [19]

For Florida patients who cannot tolerate oral bisphosphonates due to gastrointestinal side effects, once-yearly IV zoledronic acid may be preferable clinically and financially, particularly if administered through an FQHC where 340B pricing applies. The HORIZON-PFT trial (N=7,765) showed zoledronic acid reduced hip fracture by 41% and vertebral fracture by 70% over 3 years. [20]

Correct Dosing and Administration in Florida Telehealth and Clinical Settings

The FDA-approved dose of alendronate for postmenopausal osteoporosis is 70 mg orally once weekly or 10 mg orally once daily. The once-weekly formulation is identical in efficacy to the daily regimen and is preferred for adherence. [15]

Administration instructions are strict. The tablet must be swallowed whole (not crushed or chewed) with at least 6 oz of plain water immediately upon rising, before any food, drink, or other medication. The patient must remain upright (sitting or standing) for at least 30 minutes afterward. [15] Poor adherence to these instructions is the leading cause of esophageal adverse events, which include esophagitis and, rarely, esophageal ulceration.

Contraindications include esophageal abnormalities that delay esophageal emptying (stricture, achalasia), inability to stand or sit upright for 30 minutes, hypocalcemia, and creatinine clearance below 35 mL/min. [15] Prescribers should check a basic metabolic panel and correct any hypocalcemia or vitamin D deficiency before starting therapy. The Institute of Medicine recommends 800, 1 to 000 IU of vitamin D daily for adults over 70, and calcium intake of 1 to 200 mg/day from food and supplement combined. [21] Alendronate does not work optimally in a vitamin D-deficient patient.

Duration of therapy in standard practice is 5 years for most patients, followed by reassessment. High-risk patients (prior hip fracture, T-score below -2.5 at the hip after 5 years of treatment, or ongoing glucocorticoid use) may benefit from continued therapy beyond 5 years, per the 2022 American College of Rheumatology guidelines on glucocorticoid-induced osteoporosis. [22]

Monitoring Alendronate Therapy: What Florida Patients Should Expect

After starting alendronate, the standard monitoring schedule includes a repeat DXA scan at 1 to 2 years to assess BMD response. Patients who show no BMD gain (or continued loss) should be evaluated for secondary causes of osteoporosis, poor adherence, or inadequate calcium and vitamin D intake before switching therapy. [12]

Bone turnover markers (BTMs) like serum CTX and procollagen type 1 N-terminal propeptide (P1NP) can be checked at 3 months. A CTX reduction of at least 25 to 50% from baseline suggests adequate biologic response. [16] This marker-based monitoring approach is practical in telehealth settings because results are available through standard labs without an in-person visit.

Dental evaluation before starting alendronate is recommended but not mandatory for patients on oral doses for osteoporosis. The American Dental Association advises patients to inform their dentist of bisphosphonate use before any invasive dental procedure, given the small ONJ risk. [23] Florida patients should share their medication list at every dental visit.

Kidney function monitoring matters. If creatinine clearance drops below 35 mL/min during therapy, alendronate should be discontinued. [15] Annual basic metabolic panel review is reasonable in patients over 70, where renal function decline is more common.